Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00253357 · ClinicalTrials.gov registry record

PROSPECT: Predictors of Response to Cardiac Re-Synchronization Therapy

A clinical trial of Heart Failure and Congestive Heart Failure, sponsored by Medtronic Cardiac Rhythm and Heart Failure.

Completed
Registry status
450
Enrollment target
20
Study locations

NCT00253357 is a study of Heart Failure and Congestive Heart Failure that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 450 participants, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (78% lower). The trial reports 20 study locations across 17 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00253357, a study of Heart Failure and Congestive Heart Failure, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.

COMPLETED
Registry status
450 participants
Enrollment target
20
Study locations

Study Summary

Heart failure is a progressive disease that decreases the pumping action of the heart. This may cause a backup of fluid in the heart and may result in heart beat changes. Using a medical device like a pacemaker or a defibrillator can help the heart to pump in regular beats. However, not all patients do better with a device. Currently, there is not a way to identify which patients will benefit from the device. The purpose of this study is to determine if using medical tests, Echocardiogram, can help in predicting which patients will improve. The types of patients needed for this study are those who have been diagnosed with moderate or severe heart failure.

Conditions Studied

Heart Failure Congestive Heart Failure Cardiomyopathy

Study Locations (20)

Other

  • - Several Locations
  • - Several Locations
  • - Several Locations
  • - Several Locations

California

  • - Several Locations

Florida

  • - Gainsville

Georgia

  • - Atlanta

Illinois

  • - Columbus

Kansas

  • - Kansas City

Louisiana

  • - New Orleans

Michigan

  • - Grand Rapids

Trial Details

FieldValue
Enrollment Target 450 participants
Start Date 2004-03
Est. Completion 2006-06

Sponsor

Medtronic Cardiac Rhythm and Heart Failure

115 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00253357

The ClinicalTrials.gov registry entry for NCT00253357 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 450 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (78% lower). The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Heart Failure appearing as the primary indexed condition, and to 0 interventions.

NCT00253357 reports 20 study locations spanning 17 distinct geographic areas - top geographies include Other, California, Florida.

Frequently Asked Questions

What is clinical trial NCT00253357 about?

NCT00253357 is a clinical study titled "PROSPECT: Predictors of Response to Cardiac Re-Synchronization Therapy". Heart failure is a progressive disease that decreases the pumping action of the heart. This may cause a backup of fluid in the heart and may result in heart beat changes. Using a medical device like a pacemaker or a defibrillator can help the heart to pump in regular beats. However, not all patients...

What is the current status of trial NCT00253357?

This trial is currently completed. The enrollment target is 450 participants. The study started on 2004-03. Estimated completion is 2006-06.

What conditions does trial NCT00253357 study?

This clinical trial studies the following conditions: Heart Failure, Congestive Heart Failure, Cardiomyopathy.

Who is sponsoring clinical trial NCT00253357?

This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00253357 being conducted?

This trial has 20 study locations across California, Florida, Georgia, Illinois, Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Heart Failure

All registered trials for this condition

Congestive Heart Failure

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.